Help accelerate Southern Research's work against COVID-19.
Learn More
We’ve created seven drugs that are helping win the war on cancer. More are on the way. When HIV threatened the world’s future, we helped develop a course of treatment that changed the course of history. We’re creating better ways for you to have cleaner air and water. Our technologies help men and women in uniform remain safe overseas. We’re developing methods to build energy efficient cars out of plant fiber that will get 80mpg. We are Southern Research. We’re taking on the world’s hardest problems. And solving them. This has been our mission since 1941.
And we’re just getting started.
Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission TNX-1800 is Based on a Proprietary Vaccine Platform Designed […]
Southern Research is pleased to announce the hiring of Dr. Mark Opeka to our Engineering team at Southern Research as a Materials Engineering Fellow. He previously served as a Subject […]
In honor of Women’s History Month and Histotechnology Professionals Day, Southern Research wants to take a moment to recognize our team of histotechnologists and their team leader, LaVinia Ray. She […]
Southern Research, through the ARPAe program, has been installing robotic systems in some of our labs. They are currently being used for our research into autonomous maintenance of nuclear energy […]
When the Southern Research Engineering Division talks about testing materials in extreme environments, it usually is referring to measuring properties at very high temperatures up to 5500 °F. However, going […]
On the 16th of November, 2020, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced preliminary results for a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 (CoV-2) […]
